Stock Analysis on Net

HCA Healthcare Inc. (NYSE:HCA)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 3, 2022.

Common-Size Income Statement

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

HCA Healthcare Inc., common-size consolidated income statement

Microsoft Excel
12 months ended: Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Revenues
Supplies
Gross profit
Salaries and benefits
Other operating expenses
Depreciation and amortization
Gains (losses) on sales of facilities
Operating income
Equity in earnings of affiliates
Interest expense
Losses on retirement of debt
Income before income taxes
Provision for income taxes
Net income
Net income attributable to noncontrolling interests
Net income attributable to HCA Healthcare, Inc.

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


Revenues
Remained constant at 100% across all periods, establishing the basis for relative percentage analysis.
Supplies
Displayed a slight decreasing trend as a percentage of revenues, improving from -16.77% in 2017 to -16.14% in 2021, indicating better cost control or procurement efficiency.
Gross profit
Experienced a gradual increase from 83.23% in 2017 to 83.86% in 2021, reflecting improved gross margins over the period.
Salaries and benefits
Remained relatively stable with minor fluctuations; around -45.9% of revenues, peaking slightly at -46.33% in 2020 before improving to -45.58% in 2021.
Other operating expenses
Exhibited a decreasing trend, falling significantly from -18.46% in 2017 to -16.95% in 2021, which suggests enhanced operational efficiency or cost reduction efforts.
Depreciation and amortization
Fluctuated modestly between -4.86% and -5.28%, peaking in 2020 and then reverting to lower levels by 2021, indicating some variation in capital asset utilization or investment.
Gains (losses) on sales of facilities
Showed inconsistent values with a noteworthy spike in 2021 to 2.76%, implying significant one-time gains from asset sales in the latest period compared to minimal or negative values earlier.
Operating income
Demonstrated a meaningful increase from 13.91% in 2017 to a notable 19.23% in 2021, highlighting improved operating profitability over the five-year span.
Equity in earnings of affiliates
Remained low but showed a slight upward trend, increasing from 0.1% in 2017 to 0.19% in 2021, suggesting modest growth in income contributions from affiliates.
Interest expense
Declined steadily from -3.87% in 2017 to -2.67% in 2021, indicating reduced interest burden possibly due to debt repayment or refinancing at lower rates.
Losses on retirement of debt
Varied with minor effects, reaching a low of -0.57% in 2020 but effectively negligible by 2021 at -0.02%, reflecting fewer or less costly debt retirements in recent years.
Income before income taxes
Increased from 10.04% in 2017 to 16.74% in 2021, in line with enhanced operating income and reduced financial costs, signaling stronger pre-tax profitability.
Provision for income taxes
Displayed variability, dropping from -3.76% in 2017 to about -2.0% in 2018-2020, before rising again to -3.59% in 2021, which may reflect changes in tax rates or taxable income composition.
Net income
Grew significantly, from 6.29% of revenues in 2017 to 13.14% in 2021, more than doubling over the period and indicating effective overall profitability improvement.
Net income attributable to noncontrolling interests
Remained relatively steady around -1.2% to -1.3%, suggesting consistent minority interest impact over time.
Net income attributable to HCA Healthcare, Inc.
Followed the net income trend closely, rising from 5.08% in 2017 to 11.84% in 2021, underscoring strong growth in earnings available to the parent company’s shareholders.